Is Salesforce poised to outperform with Q3 earnings?

Should you buy Salesforce shares after issuing disappointing FQ4 guidance?

On Tuesday, Salesforce.com Inc. (NYSE:CRM) shares declined by nearly 4% ahead of its FQ3 results. The stock sank further by more..